Table 2.
Echo- and electrocardiographic findings
| Group C−N− (n = 22) | Group C−N+ (n = 8) | Group C+N− (n = 4) | Group C+N+ (n = 5) | P-value | |
|---|---|---|---|---|---|
| Echocardiographic findings | |||||
| LVEF (%), median (range) | 55 (54–60) | 55 (50–65) | 55 (50–60) | 60 (38–60) | 0.875 |
| Sparkling (n) | 1 | 1 | 3 | 5 | < 0.001 |
| IVSd (mm), median (range) | 9.0 (6.0–13) | 10 (6.0–11) | 12 (8.0−16) | 17 (10−23) | 0.013 |
| ECG findings | 0.042 | ||||
| No pathological signs | 11 | 3 | 0 | 0 | |
| Conduction system disease | 3 | 3 | 1 | 1 | |
| Arrhythmia | 3 | 1 | 1 | 0 | |
| Pseudo-infarction | 3 | 1 | 0 | 3 | |
| Multiple | 1 | 0 | 2 | 1 |
Group C−N− = no cardiac autonomic neuropathy and cardiomyopathy, group C−N+=only cardiac autonomic neuropathy, group C+N− = only cardiomyopathy, group C+N+ = both cardiac autonomic neuropathy and cardiomyopathy
ECG, electrocardiography; LVEF, left ventricular ejection fraction; IVSd, interventricular wall thickness at end-diastole; mm, millimeter; n, number